These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 418431)

  • 1. The social outcome of patients in a trial of long-term continuation therapy in schizophrenia: pimozide vs. fluphenazine.
    Falloon I; Watt DC; Shepherd M
    Psychol Med; 1978 May; 8(2):265-74. PubMed ID: 418431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia.
    Falloon I; Watt DC; Shepherd M
    Psychol Med; 1978 Feb; 8(1):59-70. PubMed ID: 345313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medico-social evaluation of the long-term pharmacotherapy of schizophrenia. Comparative study of fluphenazine and pimozide.
    Shepherd M
    Prog Neuropsychopharmacol; 1979; 3(4):383-9. PubMed ID: 401349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluations of social functioning in a 3-year double-blind investigation of pimozide versus fluphenazine in chronic schizophrenia [proceedings].
    Abuzzahab FS
    Psychopharmacol Bull; 1977 Jan; 13(1):71-3. PubMed ID: 319477
    [No Abstract]   [Full Text] [Related]  

  • 5. Intermittent pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia.
    McCreadie RG; Dingwall JM; Wiles DH; Heykants JJ
    Br J Psychiatry; 1980 Dec; 137():510-7. PubMed ID: 7011468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once weekly pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia.
    McCreadie R; Mackie M; Morrison D; Kidd J
    Br J Psychiatry; 1982 Mar; 140():280-6. PubMed ID: 7093596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of fluphenazine decanoate in lessening the burden of chronic schizophrenics on the community.
    Stevens BC
    Psychol Med; 1973 May; 3(2):141-58. PubMed ID: 4577254
    [No Abstract]   [Full Text] [Related]  

  • 8. A three-year double-blind investigation of pimozide versus fluphenazine in chronic schizophrenia.
    Abuzzahab FS; Zimmermann RL
    Psychopharmacol Bull; 1976 Apr; 12(2):26-7. PubMed ID: 769023
    [No Abstract]   [Full Text] [Related]  

  • 9. Activity in chronic schizophrenic patients: comparison of pimozide with fluphenazine in a double blind trial.
    Sims AC; Burnside IG
    Psychol Med; 1975 May; 5(2):161-4. PubMed ID: 1099598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pimozide versus fluphenazine in ambulatory schizophrenics: A 12-month comparison study.
    Donlon PT; Swaback DO; Osborne ML
    Dis Nerv Syst; 1977 Feb; 38(2):119-23. PubMed ID: 319967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the Social Behaviour Assessment Schedule (SBAS) in a trial of maintenance antipsychotic therapy in schizophrenic outpatients: pimozide versus fluphenazine.
    Barnes TR; Milavic G; Curson DA; Platt SD
    Soc Psychiatry; 1983; 18(4):193-9. PubMed ID: 6356386
    [No Abstract]   [Full Text] [Related]  

  • 12. Factors determining patient tenure on a 3-year double-blind investigation of pimozide versus fluphenazine HCl.
    Abuzzahab FS; Zimmermann RL
    Adv Biochem Psychopharmacol; 1980; 24():547-50. PubMed ID: 7405675
    [No Abstract]   [Full Text] [Related]  

  • 13. The natural history of schizophrenia: a 5-year prospective follow-up of a representative sample of schizophrenics by means of a standardized clinical and social assessment.
    Watt DC; Katz K; Shepherd M
    Psychol Med; 1983 Aug; 13(3):663-70. PubMed ID: 6353463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate.
    Cookson JC; Kennedy NM; Gribbon D
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():41-51. PubMed ID: 3549879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pimozide and the social behavior of schizophrenics.
    Lapierre YD; Lavallee J
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):181-88. PubMed ID: 809233
    [No Abstract]   [Full Text] [Related]  

  • 16. Weekly pimozide versus fluphenazine decanoate in schizophrenic out-and day-patients.
    McCreadie RG; McKane JP; Mackie M
    Br J Psychiatry; 1983 Jul; 143():97-8. PubMed ID: 6349740
    [No Abstract]   [Full Text] [Related]  

  • 17. A multicenter multidimensional study of some new longacting neuroleptic drugs.
    Acta Psychiatr Scand Suppl; 1974; 249():1-134. PubMed ID: 4608507
    [No Abstract]   [Full Text] [Related]  

  • 18. The contribution of fluphenazine enanthate and decanoate in the prevention of readmission of schizophrenic patients.
    Denham J; Adamson L
    Acta Psychiatr Scand; 1971; 47(4):420-30. PubMed ID: 4336483
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
    Chouinard G; Annable L; Campbell W
    J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pimozide versus chlorpromazine in chronic schizophrenia: a 52 week double-blind study of maintenance therapy.
    Wilson LG; Roberts RW; Gerber CJ; Johnson MH
    J Clin Psychiatry; 1982 Feb; 43(2):62-5. PubMed ID: 7035441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.